FIELD: medicine.
SUBSTANCE: substance of the method consists in blood serum analysis for tissue inhibitor of matrix metalloprotein kinase type 1. Herewith if the content of tissue inhibitor of matrix metalloprotein kinase type 1 does not exceed 710 ng/ml, favourable disease outcome is predicted, while its content exceeding 710 ng/ml shows fatal outcome within three months.
EFFECT: higher accuracy of disease outcome estimation in elderly and old patients suffering from cardiac insufficiency.
3 ex, 1 dwg
Authors
Dates
2009-04-27—Published
2007-12-21—Filed